BKT:BMEBankinter SA Analysis
Data as of 2026-03-14 - not real-time
$10.74
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
BlackRock Income Trust (BKT) is trading at $10.74, well below its 20‑day ($11.03), 50‑day ($11.08) and 200‑day ($11.33) simple moving averages, signaling a bearish price trend. The RSI of 18 indicates the stock is deeply oversold, while the MACD remains in a bearish configuration and the price sits just above the identified support at $10.70, with resistance near $11.17. Volume is increasing, suggesting renewed interest, but 30‑day volatility sits around 5% and the beta of 0.107 points to very low systematic risk. The dividend yield is an eye‑catching 9.77% but the payout ratio exceeds 110%, raising concerns about sustainability, especially given negative operating cash flow and a steep revenue decline of 33.6%.
Valuation metrics paint a mixed picture: the DCF‑derived fair value of $7.82 is substantially lower than the current price, implying the stock is overvalued relative to intrinsic estimates. While the P/E (11.3) is below the industry average (16.35) and the price‑to‑book (0.93) is under 1, the fund carries a heavy debt load (DE ratio 22.9) and a declining revenue base, which together with the unsustainable dividend policy elevate the risk profile. Investors should weigh the high yield against the likelihood of dividend cuts and the broader bearish technical backdrop.
Valuation metrics paint a mixed picture: the DCF‑derived fair value of $7.82 is substantially lower than the current price, implying the stock is overvalued relative to intrinsic estimates. While the P/E (11.3) is below the industry average (16.35) and the price‑to‑book (0.93) is under 1, the fund carries a heavy debt load (DE ratio 22.9) and a declining revenue base, which together with the unsustainable dividend policy elevate the risk profile. Investors should weigh the high yield against the likelihood of dividend cuts and the broader bearish technical backdrop.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- RSI at 18 suggests potential short‑term bounce
- High dividend yield of 9.77% attracts income seekers
- Bearish technicals (price below SMAs, MACD) limit upside
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- DCF fair value ($7.82) far below market price
- Unsustainable dividend payout (>110% of earnings)
- Elevated debt‑to‑equity ratio (22.9) and falling revenue
Long Term
> 3 yearsCautious
Model confidence: 8/10
Key Factors
- Likelihood of dividend reductions as cash flow remains negative
- High leverage and ongoing revenue contraction
- Persistent bearish trend with limited catalyst for recovery
Key Metrics & Analysis
Financial Health
Revenue Growth-33.60%
Profit Margin203.10%
P/E Ratio11.3
ROE7.94%
ROA1.29%
Debt/Equity22.93
P/B Ratio0.9
Op. Cash Flow$-72030544
Free Cash Flow$24.9M
Industry P/E16.4
Technical Analysis
TrendBearish
RSI18.0
Support$10.70
Resistance$11.17
MA 20$11.03
MA 50$11.08
MA 200$11.33
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair Value$7.82
GradeOvervalued
TypeValue
Dividend Yield9.77%
Risk Assessment
Beta0.11
Volatility5.03%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.